How to tell if research peptides are real

There is no visual test that can tell you whether a research peptide is authentic. A white lyophilized material may be the expected peptide, something else, or a mixture. Packaging does not settle the question either. And a label that says 99% purity still leaves the question of identity unanswered. When research peptides are examined in a laboratory, “real” is too vague to be a test result. A researcher might confirm the identity of a sample, run HPLC to examine its purity, or measure peptide content. Depending on the work, specific impurities may need to be investigated as well. Each analysis tells you something different about the material. Start with the batch number Check whether the lot number on the vial matches the one shown on the COA. If it doesn't, the report cannot be treated as test data for that batch. Peptide name alone isn't enough – production lots are tested as individual samples. This is the problem with a generic COA: there may be no clear link between the material being checked and the material the laboratory actually received. A batch-specific COA is intended to keep that connection between the analytical results and the individual production lot. The other details are fairly ordinary but easy to overlook. Who ran the analysis? When? Is there a report number? Does the testing laboratory allow that number to be checked against its own records? If there is a chromatogram or mass spectrum, is it part of the same report? At Purita, testing is handled on a batch basis: every batch undergoes two independent tests and receives its own documentation. That keeps the analytical results attached to the material they were generated from rather than carrying one report forward from batch to batch. This brings us back to the practical question of how to know if your peptides are real: what do those tests actually tell you? A purity result is not an identity result This is probably the most common source of confusion. HPLC separates the components of a sample rather than simply giving it a pass or fail. In peptide analysis, those components appear as peaks on a chromatogram. One peak may dominate, with several much smaller ones around it. The relative peak areas are then used to report chromatographic purity under the conditions of that particular analysis. For a closer look at how to test peptides for purity , including what an HPLC purity percentage does and does not mean, see our separate guide. Say the report gives 99%. What does that number actually describe? In this case, it comes from the relative area of the main chromatographic peak. It is a purity result, not a name tag for the molecule behind that peak. The chromatogram could still contain one very large peak. Its size would not somehow reveal the name of the molecule producing it. That is the distinction. HPLC can tell you a great deal about the chromatographic composition of a sample. The purity percentage alone does not establish the molecular identity of its main component. There is a second trap in the 99% figure. It is easy to read it as “99% of everything in this vial is the target peptide.” That isn't what an HPLC peak-area result says. The HPLC peak-area percentage should not be read as a complete mass balance for everything in the vial. Water, counterions and residual solvents, for example, may need to be accounted for separately when peptide content is assigned. Peptide salts also include counterions, and other residual material may be present depending on how the sample was made and processed. So there are two numbers that are easy to confuse: chromatographic purity and the actual amount of peptide in the material. They are not interchangeable. Reference-standard work reflects that difference too – identity, purity and peptide content are determined as separate characteristics, with the analysis chosen for each one. So how is identity checked? If the question is how to test if peptides are real, identity testing is central to the answer. Mass spectrometry is commonly part of that work. With MS, the question changes. The laboratory now has a measured mass to compare with the mass expected for the peptide. The instrument gets there by turning molecules into ions and recording their mass-to-charge ratios. That gives the laboratory experimental values to put against the values expected for the proposed peptide. What if they don't line up? That would count against the proposed identity. If they do agree, the result supports the identification – although it still has to be interpreted in light of the method used. Notice the qualification there. A matching mass can be very informative, but mass is not a unique fingerprint in every situation. Different structures may have the same mass. Peptide synthesis can also leave closely related sequence variants, and stereochemical differences are a separate challenge. A basic mass measurement will not necessarily distinguish between all of them. Researchers can get more information by going beyond an intact-mass measurement. LC-MS first separates components chromatographically and then examines them by mass spectrometry. Tandem MS takes another route: selected ions are fragmented, and those fragments provide clues about peptide structure. Even these methods have limits, which is why another analytical technique may sometimes be needed. The United States Pharmacopeia's work on synthetic peptide reference standards illustrates this rather well. The characterization does not rest on one instrument reading. Mass spectrometry is used alongside other approaches, including NMR and chromatographic methods, and particular problems such as chiral or isobaric amino acids can require additional analysis. In other words, “the mass matches” is useful evidence. What it proves depends on how the analysis was performed. What to look for when checking a research peptide You do not need to interpret every ion in a mass spectrum to spot weaknesses in the documentation. If you want to know how to tell if peptides are real, start with the documentation rather than the spectrum itself. A practical peptide authenticity check begins with three simpler things: the batch, the report and the tests actually performed. Take the research peptide and the report together. Does the lot number match? If the laboratory can verify reports independently, check the report there. Then look at the tests rather than the headline claim. If you see only an HPLC purity result, you have purity data. Do not quietly turn that into identity data. If identity testing is reported, look at the method used. Mass spectrometry is common for synthetic peptides, but “MS tested” is still less informative than an actual result tied to the sample. And if a COA lists neither a laboratory nor enough information to connect the report to the batch, there is very little to verify. A certificate is a container for analytical evidence, not evidence simply because it is called a certificate. This also explains why some apparently reassuring signs do not take you very far: an intact lyophilized cake says nothing definite about molecular identity; professional packaging can help trace a sample, but cannot identify its contents; a high HPLC percentage is not an authenticity test by itself; an old COA from the same supplier does not establish the result for a new lot; a matching molecular mass is useful, but should be interpreted within the limits of the MS method used. If the question is whether the peptide is real, there is no trick involving color, texture or the amount of powder in the vial that can replace this work. How to tell if your peptides are real For a research peptide, a sensible authenticity check is surprisingly short. Start with traceability. The analytical report should belong to the batch you have. Next comes identity. Look at what the laboratory actually measured. If mass spectrometry was used, there should be a result that can be compared with the expected peptide rather than simply a